ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007

Louis Sullivan Blasts Tobacco, Sports Links

May 10, 1991

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998